Sierra Leone virus vaccine Ebola Sierra Leone

Two-dose J&J Ebola vaccine gives strong immune response

Reading now: 110

Johnson & Johnson's two-dose vaccine regimen against Ebola is safe and produces a strong immune response in people 1 year old and older, according to two studies published this week in The Lancet Infectious Diseases.The studies detailed the results of phase 2 randomized, controlled trials in Sierra Leone, which is one of the three countries that was hit hard during the massive 2014-16 West African Ebola outbreak.A potentially easier supply chainJohnson & Johnson's vaccine regimen consists of a dose of the adenovirus vector-based vaccine Ad26.ZEBOV followed 8 weeks later by a different vector-based vaccine called the MVA-BN-Filo.Because of these results, Johnson & Johnson received approval and marketing authorization from the European

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News